Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Mauro S. Treitsman"'
Autor:
Tânia R.C. Vergara, Sadia Samer, Joanna R. Santos-Oliveira, Leila B. Giron, Muhammad Shoaib Arif, Maria Luciana Silva-Freitas, Lia A. Cherman, Mauro S. Treitsman, Alberto Chebabo, Maria Cecilia A. Sucupira, Alda M. Da-Cruz, Ricardo Sobhie Diaz
Publikováno v:
EBioMedicine, Vol 23, Iss C, Pp 59-67 (2017)
Trial Design: Open-label, randomised, controlled, pilot proof-of-concept clinical trial. Methods: Participants: Antiretroviral naïve adult males with CD4 count ≥350 cells/mm3. Interventions: Patients were randomised to receive thalidomide 200 mg Q
Externí odkaz:
https://doaj.org/article/09363f00a91c4c78aec5399cf59d9400
Autor:
Joanna Reis Santos-Oliveira, Mauro S. Treitsman, Tânia Regina Constant Vergara, Sadia Samer, Ricardo Sobhie Diaz, Lia Adler Cherman, Leila B. Giron, Maria Cecília Araripe Sucupira, Alda Maria Da-Cruz, Muhammad Shoaib Arif, Maria Luciana Silva-Freitas, Alberto Chebabo
Publikováno v:
EBioMedicine, Vol 23, Iss C, Pp 59-67 (2017)
Repositório Institucional da UNIFESP
Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
EBioMedicine
Repositório Institucional da UNIFESP
Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
EBioMedicine
Trial Design Open-label, randomised, controlled, pilot proof-of-concept clinical trial. Methods Participants: Antiretroviral naïve adult males with CD4 count ≥ 350 cells/mm3. Interventions: Patients were randomised to receive thalidomide 200 mg QD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d946e075211fa22f0274ee04ed79072b
https://doi.org/10.1016/j.ebiom.2017.08.007
https://doi.org/10.1016/j.ebiom.2017.08.007